Connect
MJA
MJA

Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia

Jacqueline A Boyle, Joan Cunningham, Kerin O'Dea, Terry Dunbar and Robert J Norman
Med J Aust 2012; 196 (1): 62-66. || doi: 10.5694/mja11.10553
  • Jacqueline A Boyle1,2,3
  • Joan Cunningham2
  • Kerin O'Dea4
  • Terry Dunbar5
  • Robert J Norman3

  • 1 Jean Hailes for Women’s Health, Monash University, Melbourne, VIC.
  • 2 Menzies School of Health Research, Darwin, NT.
  • 3 The Robinson Institute, University of Adelaide, Adelaide, SA.
  • 4 The Sansom Institute, University of South Australia, Adelaide, SA.
  • 5 Australian Centre for Indigenous Knowledges and Education, Charles Darwin University, Darwin, NT.


Acknowledgements: 

We gratefully acknowledge the support of DRUID study participants, study staff, members of the Indigenous Steering Group, and partner organisations. The DRUID Study was funded by the National Health and Medical Research Council (Project Grant #236207), with additional support from the Australian Government Department of Employment and Workplace Relations, the Clive and Vera Ramaciotti Foundation, the Vincent Fairfax Family Foundation, the AusDiab Partnership in Type 2 Diabetes, and Bayer HealthCare. The DRUID study is an in-kind project of the Cooperative Research Centre for Aboriginal Health.

Jacqueline Boyle was supported by Royal Australian and New Zealand College of Obstetricians and Gynaecologists Fotheringham Research Grant, 2002; NHMRC Training Scholarship for Indigenous Australian Health Research, 2005–2009; Australian Academy of Science Douglas and Lola Douglas Scholarship, 2005–2009; and Eli Lily. Joan Cunningham was supported by an NHMRC Career Development Award (No. 283310) and NHMRC Research Fellowship (No. 545200).

Competing interests:

No relevant disclosures.

  • 1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370: 685-697.
  • 2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
  • 3. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine F, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific, 1992: 377-384.
  • 4. Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438.
  • 5. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the south eastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.
  • 6. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4119.
  • 7. Taponen S, Martikainen H, Järvelin MR, et al. Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 2004; 89: 2114-2118.
  • 8. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551.
  • 9. Goodarzi MO, Quinones MJ, Azziz R, et al. Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril 2005; 84: 766–912.
  • 10. Vos T, Barker B, Stanley L, Lopez AO. The burden of disease and injury in Aboriginal and Torres Strait Islander peoples 2003. Brisbane: School of Population Health, University of Queensland, 2007.
  • 11. Laws PJ, Hilder L. Australia’s mothers and babies 2006. Sydney: Australian Institute of Health and Welfare National Perinatal Statistics Unit, 2008. (AIHW Cat. No. PER 46; Perinatal Statistics Series No. 22.)
  • 12. Davis SR, Knight S, White V, et al. Preliminary indication of a high prevalence of polycystic ovary syndrome in Indigenous Australian women. Gynecol Endocrinol 2002; 16: 443-446.
  • 13. Cunningham J, O’Dea K, Dunbar T, et al. Study protocol — diabetes and related conditions in urban Indigenous people in the Darwin, Australia region: aims, methods and participation in the DRUID Study. BMC Public Health 2006; 6: 8.
  • 14. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
  • 15. Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 941-945.
  • 16. Poprzeczny A. Anti-Mullerian hormone as a diagnostic marker and pathogenic factor in polycystic ovary syndrome [Honours thesis]. Adelaide: University of Adelaide, 2007.
  • 17. Australian Bureau of Statistics. Experimental projections of Aboriginal and Torres Strait Islander populations, ATSIC regions. Canberra: ABS, 2004. (ABS Cat. No. 3238.0.55.002.)
  • 18. Piers LS, Rowley KG, Soares MJ, O’Dea K. Relation of adiposity and body fat distribution to body mass index in Australians of Aboriginal and European ancestry. Eur J Clin Nutr 2003; 57: 956-963.
  • 19. Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Health Survey 2004-05. Canberra: ABS, 2006. (ABS Cat. No. 4715.0.) http://www.abs.gov.au/ausstats/abs@.nsf/mf/4715.0 (accessed Oct 2011).
  • 20. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453-462.
  • 21. Teede HJ, Misso ML, Deeks AA, et al; the Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (6 Suppl): S65-S112. <MJA full text>

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.